Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Biopharmaceutics and Pharmacokinetics: Overview

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nationwide questionnaire survey on diagnostic errors in pediatric outpatient acute care.

Pediatrics international : official journal of the Japan Pediatric Society·2025

Same author

Association between baseline white blood cell count and future cardiovascular events in patients with stable coronary artery disease- Sub-analysis of the REAL-CAD trial.

American journal of preventive cardiology·2025

Same author

Severe Human Herpesvirus 7 Infection in Healthy Children.

Fukushima journal of medical science·2025

Same author

Obstructive Fibrinous Tracheal Pseudomembrane: An Uncommon Presentation.

Anesthesiology·2024

Same author

Serum mature and furin-cleaved proprotein convertase subtilisin/kexin type 9 levels and their association with cardiovascular events in statin-treated patients with cardiovascular disease.

Journal of clinical lipidology·2024

Same author

Significance of Persistent Inflammation in Patients With Chronic Coronary Syndrome: Insights From the REAL-CAD Study.

JACC. Advances·2024

Search research articles

Related Experiment Video

Updated: May 26, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Pitavastatin: an overview.

Yasushi Saito¹

¹Chiba University, Chiba, Japan. saito@office.chiba-u.jp

Atherosclerosis. Supplements

|December 14, 2011

Summary

Pitavastatin is a potent HMG-CoA reductase inhibitor with unique pharmacokinetics, offering significant LDL-C reduction and potential pleiotropic benefits. Clinical studies show its efficacy and safety, particularly in specific patient groups, suggesting cardiovascular risk reduction.

Area of Science:

Pharmacology and Cardiovascular Medicine

Background:

Pitavastatin is a potent 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase inhibitor with a unique chemical structure.
Its structure leads to improved pharmacokinetics, efficient low-density lipoprotein-cholesterol (LDL-C) receptor induction, and significant LDL-C lowering at low doses.
Pitavastatin undergoes minimal metabolism by cytochrome P450 enzymes, primarily undergoing biliary excretion and enterohepatic recirculation, contributing to its prolonged action.

Purpose of the Study:

To evaluate the efficacy and safety of pitavastatin in managing hypercholesterolemia and reducing cardiovascular risk.
To explore the pleiotropic benefits of pitavastatin beyond LDL-C lowering.

Main Methods:

Clinical trials, including the CHIBA and JAPAN-ACS studies, were conducted.
Comparative analyses with other statins like atorvastatin were performed.

Related Experiment Videos

Last Updated: May 26, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Subgroup analyses focused on patients with metabolic syndrome, insulin resistance, and chronic kidney disease.

Main Results:

Pitavastatin demonstrated significant LDL-C lowering efficacy, comparable to atorvastatin in general hypercholesterolemia.
Subgroup analyses revealed more significant improvements in lipid profiles (LDL-C, TG, HDL-C) in patients with metabolic syndrome.
Studies indicated pitavastatin's potential for plaque regression in acute coronary syndrome (ACS) patients and benefits in specific patient groups.

Conclusions:

Pitavastatin is a clinically effective and safe statin for hypercholesterolemia, offering advantages in specific patient populations.
Its unique pharmacokinetic profile and potential pleiotropic effects suggest a role in reducing residual cardiovascular risk.
Further research supports pitavastatin's utility in managing complex lipid disorders and improving cardiovascular outcomes.